sglt vs glp 1 Sodium glucose cotransport 2 (SGLT-2) inhibitors and glucagon-like Weight loss differences seen between

Staying consistent matters

Multiple clinical trialsincluding SUSTAIN-6 (semaglutide) and REWIND (dulaglutide)showed significant reductions in major adverse cardiovascular events (MACE) such as: Heart attack Stroke Cardiovascular death This benefit appears to be independent of weight loss , suggesting direct protective effects on the arteries, blood pressure, and cholesterol metabolism

Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, and Allen RH (1993)

And muscle is metabolically expensive tissue

Wilcox previously offered compounded GLP-1s through his practice, when it was removed from the FDA shortage list he stopped providing the drug

Use needles of appropriate gauge and length